摘要
发热性中性粒细胞减少症是化疗所致的严重不良反应之一,使患者住院治疗周期延长,住院费用显著增加,同时影响化疗疗效。本文主要对乳腺癌患者化疗所致的发热性中性粒细胞减少症的风险评估、影响因素,以及集落刺激因子及抗菌药物的预防和治疗作一综述。
Febrile neutropenia was one of the most serious adverse reactions caused by chemotherapy,which extended the hospitalization period and significantly increased hospitalization expenses,reduced the efficacy of chemotherapy. This review focused on making a brief description and prospect of the risk evaluation,influence factors,prevention and treatment of colony stimulating factors and antibacterials of chemotherapy-induced febrile neutropenia in patients with breast cancer.
出处
《中国肿瘤》
CAS
2015年第9期779-784,共6页
China Cancer
基金
浙江省中医药重点研究项目(2015ZZ004)
